21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
#8102COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
#8103BEVERAGE AND MEDICAMENT CONTAINING BAMBOO EXTRACT AS A MAIN INGREDIENT
#8104Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins
#8105Method of Enhancing Biological Activity of Plant Extracts
#8106STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR
#8107Mazindol combination in the treatment of attention deficit/hyperactivity
#8108Anti-viral pharmaceutical compositions
#8109ELECTROLYTE PURGATIVE
#8110MULTI-VITAMIN AND MINERAL NUTRITIONAL SUPPLEMENTS
#8111DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE
#8112COMBINATION METHODS AND COMPOSITIONS
#8113SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS
#8114Bisbenzamidines for the treatment of pneumonia
#8115Mucosal and Systemic Immunization with Alphavirus Replicon Particles
#8116METHODS FOR DELAYING THE ONSET AND/OR REDUCING THE SEVERITY OF METABOLIC SYNDROME
#8117ANTI-CANCER NUTRACEUTICAL COMPOSITION
#8118COMBINATION THERAPY USING RECEPTOR TYROSINE KINASE INHIBITORS AND ANGIOGENESIS INHIBITORS
#8119Targeting PAX2 for the treatment of breast cancer
#8120Targeting PAX2 for the treatment of breast cancer
#8121Neutraceutical-Based Topical Anxiolytic Agent and Method of Use
#8122Therapeutic/prophylactic agent for prostate cancer
#8123Therapeutic agent for hematopoietic tumors
#8124USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
#8125Neutral or alkaline medium chain peroxycarboxylic acid compositions and methods employing them
#8126Stimulation of cartilage formation using reduced pressure treatment
#8127Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
#8128ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#8129Formulations of low dose diclofenac and beta-cyclodextrin
#8130COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#8131Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions
#8132Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
#8133Methods and Compositions for Treating or Preventing Symptoms of Hormonal Variations
#8134Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
#8135METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS AND DISEASES ASSOCIATED THEREWITH
#8136Treatment of lupus nephritis using laquinimod
#8137Cyclic benzimidazole derivatives useful as anti-diabetic agents
#8138Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia
#8139SUBSTITUTED POLYAMINES AS INHIBITORS OF BACTERIAL EFFLUX PUMPS
#8140METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#8141SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE
#8142COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#8143STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS
#8144INHIBITORS OF EXTRACELLULAR PROTEASES
#8145Nutritional compositions with coated lipid globules
#8146Probiotic Derived Non-Viable Material For Allergy Prevention And Treatment
#8147Extract of aerial parts of oats harvested before ear emergence
#8148PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FIBROMYALGIA
#8149COMPOSITIONS FOR THE PROPHYLAXIS AND TREATMENT OF DERMATOLOGICAL/MUCOSAL DISEASES, AND USES THEREOF
#8150Mesoporous implants for administering substances and methods of producing implants
#8151Mesoporous implants for administering substances and methods of producing implants
#8152SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS
#8153TREATMENT OF ORTHOPEDIC CONDITIONS
#8154Targeting PAX2 for the treatment of breast cancer
#8155TREATMENT OF LUPUS ARTHRITIS USING LAQUINIMOD
#8156TREATMENT AND/OR PREVENTION OF PEANUT INDUCED ANAPHYLAXIS
#8157Keratin biomaterials for treatment of ischemia
#8158METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
#8159Medication and treatment for disease
#8160Combination pharmaceutical agents as inhibitors of HCV replication
#8161COMPOUND USEFUL FOR TREATING CELLULITE
#8162Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
#8163Compositions and methods for enhancing immune response
#8164Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier
#8165METHODS FOR USING AND IDENTIFYING MODULATORS OF DELTA-LIKE 4
#8166Side-chain crystallizable polymers for medical applications
#8167Methods for concomitant administration of colchicine and macrolide antibiotics
#8168External preparation for skin
#8169Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria
#8170Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
#8171THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ISOFLAVONES
#8172METHOD OF REDUCING CNS AND GASTROINTESTINAL SIDE AFFECTS ASSOCIATED WITH LONG-TERM DEXTROMETHORPHAN/LOW-DOSE QUINIDINE COMBINATION THERAPY
#8173Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence
#8174Administration of Dipeptidyl Peptidase Inhibitors
#8175COMBINATIONS FOR THE TREATMENT OF MIGRAINE
#8176Combination of ZD6474 and Pemetrexed
#8177P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY
#8178Modulators of pharmacokinetic properties of therapeutics
#8179Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
#8180METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#8181STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM
#8182TOPICAL COMPOSITIONS AND THE USE THEREOF
#8183METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PAIN ASSOCIATED WITH HEMATOPOIETIC CELL TRANSPLANTATION
#8184AGENT FOR TREATMENT OF DIABETES
#8185Diet and methods for improving learning capacity, mood and behavior in mammals
#8186Composition and method for reducing blood glucose levels
#8187Skin whitening composition containing chia seed extract
#8188HANGOVER RELIEF BY COMPOSITIONS COMPRISING ORAL REHYDRATION SOLUTION
#8189Herbal ointment for musculoskeletal and joint-related conditions
#8190INGESTIBLES CONTAINING SUGAR AND CINNAMON OR GINSENG
#8191Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng
#8192GASTRORETENTIVE ORAL HIGH DOSE ZINC PREPARATIONS
#8193COMPOSITION FOR TREATING AUTOIMMUNE DISORDERS
#8194CICLOPIROX AND CYTARABINE FOR THE TREATMENT OF LEUKEMIC DISORDERS
#8195COMBINATION PREPARATION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR
#8196Administration of an adsorbent polymer for treatment of systemic inflammation
#8197Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
#8198Sustained release formulations using non-aqueous carriers
#8199Oligodeoxynucleotide and its use to induce an immune response
#8200METHOD FOR ENHANCING AN IMMUNE RESPONSE
#8201NEUREGULIN/ERBB SIGNALING AND INTEGRIN
#8202METHODS OF MODULATING IL-22 AND IL-17
#8203MATERIALS AND METHODS FOR INHIBITING CANCER CELL INVASION
#8204TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#8205METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN
#8206Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
#8207METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#8208Cycloundecadepsipeptide compounds and use of said compounds as a medicament
#8209NEURODEGENERATIVE DISORDERS
#8210METHODS AND COMPOSITIONS OF TREATING AND PREVENTING AUTOIMMUNE DISEASES
#8211Side-chain crystallizable polymers for medical applications
#8212Polymer Therapy for the Treatment of Chronic Microvascular Diseases
#8213COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LIPOXYGENASE INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#8214METHODS FOR PREVENTING AGGREGATION OF ADIPOSE STROMAL CELLS
#8215INTRAVAGINAL DELIVERY SYSTEM AND PROCESS FOR MANUFACTURING IT
#8216Gas mist pressure bath system
#8217Compounds that inhibit (block) bitter taste in composition and methods of making same
#8218Methods for concomitant administration of colchicine and macrolide antibiotics
#8219COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY
#8220Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
#8221Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients
#8222Combination Therapy for Breast Cancer Treatment
#8223Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
#8224Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
#8225COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC DISEASES
#8226Antimicrobial compositions
#8227Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
#8228PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT
#8229PHARMACEUTICAL COMBINATION OF ANTIBACTERIAL AND ANTIFUNGAL CREAM
#8230SN-38 COMPOSITIONS
#8231METHOD FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
#8232P70 S6 kinase inhibitor and EGFR inhibitor combination therapy
#8233METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE
#8234TREATMENT OF ANXIETY DISORDERS
#8235COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS
#8236Therapeutic compounds
#8237Compositions for treating rosacea
#8238MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM
#8239Oral B12 Therapy
#8240Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine
#8241COBALAMIN COMPOSITIONS FOR THE TREATMENT OF CANCER
#8242Fulvic acid and antibiotic combination
#8243Oral Formulations of Chemotherapeutic Agents
#8244Low side effect pharmaceutical composition containing isoniazid
#8245METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES
#8246METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION
#8247METHOD OF PROMOTING BONE GROWTH WITH HYALURONIC ACID AND GROWTH FACTORS
#8248Method of regulating proliferation and differentiation of keratinocyes
#8249Fibroblast growth factor (FGF) analogs and uses thereof
#8250High purity lipopeptides
#8251Fuel Cell System and Method for Operation of a Fuel Cell System
#8252COMPOSITIONS COMPRISING VITAMINS
#8253Antimicrobial Foamable Soaps
#8254NOVEL HERBAL COMPOSITION
#8255and iridoid based formulations
#8256Acai and Iridoid Based Formulations
#8257PIPERIDINE MODULATORS OF DOPAMINE RECEPTOR
#8258MORPHINAN MODULATORS OF NMDA RECEPTORS, SIGMA1 RECEPTORS, SIGMA2 RECEPTORS, AND/OR A3B4 NICOTINIC RECEPTORS
#8259Gastric ulcer therapeutic agent
#8260Antipyrotic formulation for the treatment of epidermal burns
#8261ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 MICRONS TO ABOUT 10 MICRONS
#8262DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#8263STABLE DOSAGE FORMS OF ANTIHYPERTENSIVE AGENTS
#8264CCR7 ligand delivery and co-delivery in immunotherapy
#8265DITHIOCARBAMATE METAL CHELATES AND METHODS OF MAKING AND USING THEREOF
#8266METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION
#8267Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
#8268Pharmaceutical Composition For Purifying Blood Vessels And Preparation Method Thereof
#8269FERMENTED SOY NUTRITIONAL SUPPLEMENTS INCLUDING MUSHROOM COMPONENTS
#8270Methods for the treatment of graft-versus-host disease
#8271Yersinia SPP. Polypeptides and Methods of Use
#8272POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#8273TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#8274TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#8275Anti-angiogenesis therapy for the treatment of ovarian cancer
#8276TRIMETHOXYPHENYL INHIBITORS OF TYROSINE KINASE
#8277METHODS AND TREATMENT FOR ALLERGIES AND INFLAMMATION ASSOCIATED WITH GASTROINTESTINAL DISEASES
#8278Methods of Modulating Gastrointestinal Tract Flora Levels with Alkaline Phosphatase
#8279Treatment of bone-related cancers using placental stem cells
#8280Engineered synergistic oncolytic viral symbiosis
#8281Antiviral agents
#8282Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
#8283Uses of IL-12 in hematopoiesis
#8284Effervescent compositions comprising phosphonates and methods related thereto
#8285MODIFIED POLYSACCHARIDES FOR DRUG AND CONTRAST AGENT DELIVERY
#8286Replaceable decorative cover for watches with digital display
#8287COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY
#8288Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
#8289Methods to regulate polarization of excitable cells
#8290ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
#8291THERAPEUTIC COMBINATION
#82924,6-diaminopyrimidine stimulators of soluble guanylate cyclase
#8293Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients
#8294METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA
#8295PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#8296METHOD AND COMPOSITION FOR TREATMENT OF SKIN CONDITIONS
#8297Method of Improving the Overall Health of a Patient by Application of Pregnenolone
#8298Small molecule inhibitors of stat3 with anti-tumor activity
#8299PHARMACEUTICAL COMPOSITION WITH GLYCOSAMINOGLYCANS AND USE THEREOF IN THE TREATMENT OF CHRONIC ULCERS
#8300Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine
#8301PHYOTOCHEMICAL COMPOSITION AND A PROCESS THEREOF
#8302LUTEOLIN AND DIOSMIN/DIOSMETIN AS NOVEL STAT3 INHIBITORS FOR TREATING AUTISM
#8303Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain
#8304METHOD AND APPARATUS FOR PRODUCTION OF A SKIN GRAFT AND THE GRAFT PRODUCED THEREBY
#8305ANTIVIRAL AGENT AGAINST ANIMAL VIRUSES
#8306Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells
#8307Compositions for prophylaxis or treatment of cerebrovascular diseases, for improving memory impairment, or for protecting neuronal cells, containing ethanol extract from , and
#8308INCREASING THE EFFICIENCY OF UTILIZATION OF INGESTED CREATINE
#8309Compositions and methods for treating depression
#8310METHODS FOR TREATING GLIOBLASTOMA WITH HERBAL COMPOSITIONS
#8311BIFEPRUNOX MESYLATE MAINTENANCE DOSE COMPOSITIONS AND METHODS FOR USING THE SAME
#8312COMPOSITIONS OF MODULATORS OF THE WNT/B-CATENIN PATHWAY AND AN N-CINNAMYL-N'BENZHYDRYL PIPERAZINE AND THEIR USE IN TREATING NEOPLASTIC CONDITIONS INCLUDING MALIGNANT MELANOMA
#8313Drug delivery vehicles, methods of manufacture, and methods of use thereof
#8314Oxidized heparin fractions and their use in inhibiting angiogenesis
#8315PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS ASSOCIATED WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS
#8316Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
#8317Compositions and methods for treating cancer
#8318ERBB4 INHIBITORS AND USES THEREOF IN TREATMENT OF NEUROPSYCHIATRIC DISORDERS
#8319COMBINATION THERAPY OF BETA-GLYCOLIPIDS AND ANTIBODIES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS
#8320Use of B Cell Expansion Agents in Generating Antibodies
#8321Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders
#8322COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR
#8323Combination Therapy for the Treatment of Ocular Neovascular Disorders
#8324Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
#8325LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
#8326Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
#8327USE OF PROTEASES FOR GLUTEN INTOLERANCE
#8328Treatment or Prevention of Hepatitis C with Immunomodulator Compounds
#8329CHEMOPREVENTION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS
#8330THERAPEUTIC AGENT FOR HEPATITIS C
#8331CARTILAGE REPAIR MIXTURE CONTAINING ALLOGRAFT CHONDROCYTES
#8332Atherosclerotic Plaque Dissolution Composition
#8333Compositions and methods for influencing satiety, lipid metabolism, and fat utilization
#8334Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
#8335Compositions and methods for treating varicose veins
#8336COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
#8337Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
#8338Substituted arylpyrazoles
#8339Controlled Release Formulations of Opioids
#8340TREATMENT WITH CHOLINERGIC AGONISTS
#8341COMBINATION OF A PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR AND A MTOR INHIBITOR
#8342COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#8343Treating psychological conditions using muscarinic receptor Mantagonists
#8344NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR
#8345Drug combinations for the treatment of duchenne muscular dystrophy
#8346PURIFIED BETA GLUCAN COMPOSITION
#8347Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
#8348COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL
#8349Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate
#8350USE OF TOCOTRIENOL COMPOSITION FOR THE PREVENTION OF CANCER
#8351TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS
#8352METHODS FOR THE CLASSIFICATION AND DIAGNOSIS OF SCOLIOSIS THROUGH THE USE OF GI PROTEIN RECEPTOR
#8353Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#8354Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#8355Dermo-cosmetic composition for pets
#8356Drop pill for treating coronary heart disease and preparation thereof
#8357Dermcidin-derived peptides for lung cancer diagnostics
#8358Compositions and methods for treating inflammatory disorders
#8359Tissue targeted antigenic activation of the immune response to treat cancers
#8360Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen
#8361Therapy-enhancing glucan
#8362QUINOLINE INHIBITORS OF TYROSINE KINASE
#8363Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#8364Cardiovascular support supplement and compositions and methods thereof
#8365USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#8366COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#8367ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS
#8368ERYTHROPOIETIN AMELIORATES CHEMOTHERAPY-INDUCED TOXICITY IN VIVO
#8369Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
#8370Administration of Dipeptidyl Peptidase Inhibitors
#8371Portable stand and mount for securing a portable media or audio player to a support
#8372METHODS OF INDUCING PLURIPOTENCY INVOLVING OCT4 PROTEIN
#8373METHODS OF INDUCING PLURIPOTENCY INVOLVING SOX2 PROTEIN
#8374USE OF IMMUNOSUPPRESSANT COMPOUNDS IN A NEW INDICATION
#8375Methods for concomitant administration of colchicine and a second active agent
#8376Methods for concomitant administration of colchicine and macrolide antibiotics
#8377OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME
#8378Compositions and Methods of Using (R)- Pramipexole
#8379METHODS FOR TREATING CNS DISORDERS
#8380Treatment of Psychosis with a 5HT2A Antagonist and a Metabotropic Glutamate Receptor Agonist or Potentiator
#8381Pharmaceutical compositions and their methods of use
#8382Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof
#8383Use of CDK inhibitor for the treatment of glioma
#8384PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST
#8385Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
#8386AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS
#8387Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
#8388METHODS OF TREATING THROMBOEMBOLIC DISORDERS
#8389METHOD FOR TREATING TUBERCULOSIS
#8390COMPOSITIONS INCLUDING CLAVULANIC ACID AND RELATED METHODS OF USE
#8391Nuclear factor kappa B pathway inhibitor composition and use of same
#8392BMI-1 protein expression modulators
#8393Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade
#8394Taxane- and taxoid-protein compositions
#8395Combination Therapy for Tuberculosis
#8396METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
#8397Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
#8398METHODS OF AIDING IN THE DIAGNOSIS OF PROSTATE CANCER
#8399Compositions and methods for the prevention and treatment of metabolic diseases
#8400METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS